Related references
Note: Only part of the references are listed.Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Kristin N. Adams et al.
CELL (2011)
Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Bacteria in a Murine Pneumonia Model
Zhe Yuan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Functional relationship between bacterial cell density and the efficacy of antibiotics
Klas I. Udekwu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances Insights from the Society of Infectious Diseases Pharmacists
Ronald G. Hall et al.
PHARMACOTHERAPY (2009)
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii
Tze-Peng Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption
Justin J. Wilkins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death
Michael A. Kohanski et al.
CELL (2008)
Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis
David M. Tobin et al.
CELLULAR MICROBIOLOGY (2008)
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis
Timothy P. Stinear et al.
GENOME RESEARCH (2008)
Accelerated evolution of resistance in multidrug environments
Matthew Hegreness et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Drug interactions modulate the potential for evolution of resistance
Jean-Baptiste Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A common mechanism of cellular death induced by bactericidal antibiotics
Michael A. Kohanski et al.
CELL (2007)
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Patient adherence to tuberculosis treatment: A systematic review of qualitative research
Salla A. Munro et al.
PLOS MEDICINE (2007)
Isoniazid bactericidal activity and resistance emergence: Integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species:: Analysis by a new response surface model
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M-tuberculosis
Roberto Colangeli et al.
PLOS PATHOGENS (2007)
Antibiotic interactions that select against resistance
Remy Chait et al.
NATURE (2007)
Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli
Daniel J. Dwyer et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis:: Evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy
Radha K. Shandil et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity
Laura E. Swaim et al.
INFECTION AND IMMUNITY (2006)
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy
Digby F. Warner et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Ancestral antibiotic resistance in Mycobacterium tuberculosis
RP Morris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance
T Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol
R Colangeli et al.
MOLECULAR MICROBIOLOGY (2005)
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat
DM Jonker et al.
EPILEPSIA (2004)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Isoniazid pharmacokinetics-pharmaco dynamics in an aerosol infection model of tuberculosis
R Jayaram et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling
T Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens
RR Regoes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis
R Jayaram et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats
M Déciga-Campos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates
J Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics
EB Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters
MR Jacobs
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Share Paper
